MarketCap
Facebook
X
TelegramQuarterly report 2025-Q3
added 11-19-2025
OpGen ROCE Ratio 2011-2026 | OPGN
Annual ROCE Ratio OpGen
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 4.4 | 265.96 | -456.3 | -56.46 | -50.72 | -200.09 | -288.45 | -834.05 | -512.09 | -163.86 | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 265.96 | -834.05 | -229.17 |
Quarterly ROCE Ratio OpGen
| 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -8.67 | -28.01 | -46.65 | 3.16 | -130.05 | -237.01 | -325.44 | -263.62 | -360.57 | -324.32 | -268.42 | -133.33 | -148.6 | -66.93 | -63.11 | -44.33 | -73.47 | -87.34 | -102.65 | -78.75 | -158.54 | -209.18 | -238.53 | -227.52 | -325.15 | -342.99 | -381.28 | -287.18 | -515.33 | -645.86 | -846.53 | -880.6 | -1032.32 | -955.88 | -815.12 | -451.34 | -513.47 | -423.88 | -306.33 | -136.67 | -117.07 | -35.34 | 23.4 | 52.36 | 52.36 | 32.76 | 14.78 | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 52.36 | -1032.32 | -265.08 |
ROCE Ratio of other stocks in the Diagnostics research industry
| Issuer | ROCE Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Akumin
AKU
|
58.25 | - | -17.87 % | $ 25.9 M |  Canada |
|
Centogene N.V.
CNTG
|
-89.9 | - | -6.23 % | $ 30.6 M |  Germany |
 |
Co-Diagnostics
CODX
|
-236.6 | $ 1.6 | -3.03 % | $ 2.13 M |  USA |
 |
Agilent Technologies
A
|
25.0 | $ 114.83 | -0.68 % | $ 34.9 B | USA |
 |
Accelerate Diagnostics
AXDX
|
62.7 | - | -61.36 % | $ 2.46 M | USA |
 |
Chembio Diagnostics
CEMI
|
-132.81 | - | 0.22 % | $ 16.8 M | USA |
 |
Aspira Women's Health
AWH
|
114.15 | - | -6.19 % | $ 10.5 M | USA |
 |
Biocept
BIOC
|
-360.98 | - | -13.05 % | $ 7.29 M | USA |
 |
Castle Biosciences
CSTL
|
1.9 | $ 24.69 | -1.18 % | $ 686 M | USA |
 |
Check-Cap Ltd.
CHEK
|
1809.55 | - | - | $ 9.42 M |  Israel |
 |
Enzo Biochem
ENZ
|
-22.04 | - | -8.98 % | $ 14.8 K | USA |
 |
Illumina
ILMN
|
-35.1 | $ 126.51 | -1.57 % | $ 20.1 B | USA |
 |
CareDx, Inc
CDNA
|
-10.16 | $ 21.98 | 0.59 % | $ 1.17 B | USA |
 |
Oxford Immunotec Global PLC
OXFD
|
-2.26 | - | - | $ 562 M |  Britain |
 |
DermTech
DMTK
|
-181.44 | - | -11.32 % | $ 2.94 M | USA |
 |
Exact Sciences Corporation
EXAS
|
-8.59 | - | - | $ 19.8 B | USA |
 |
Lantheus Holdings
LNTH
|
28.52 | $ 83.3 | -0.97 % | $ 5.62 B | USA |
 |
Fulgent Genetics
FLGT
|
-6.52 | $ 15.33 | -1.73 % | $ 464 M | USA |
 |
HTG Molecular Diagnostics
HTGM
|
-219.45 | - | -20.0 % | $ 1.06 M | USA |
 |
Global Cord Blood Corporation
CO
|
12.48 | - | - | $ 399 M |  China |
 |
Fluidigm Corporation
FLDM
|
-18.87 | - | 1.08 % | $ 308 M | USA |
 |
Genetic Technologies Limited
GENE
|
-347.69 | - | - | $ 7.1 B |  Australia |
 |
Genetron Holdings Limited
GTH
|
-15.41 | - | 0.12 % | $ 80.1 M | China |
 |
National Research Corporation
NRC
|
161.47 | $ 16.92 | -1.11 % | $ 379 M | USA |
 |
Charles River Laboratories International
CRL
|
0.8 | $ 165.87 | -3.13 % | $ 8.22 B | USA |
 |
PRA Health Sciences, Inc.
PRAH
|
9.75 | - | - | $ 10.7 B | USA |
 |
Koninklijke Philips N.V.
PHG
|
6.33 | $ 27.05 | -1.78 % | $ 20 B |  Niderland |
 |
Guardant Health
GH
|
440.3 | $ 82.95 | -6.27 % | $ 10.4 B | USA |
 |
Precipio
PRPO
|
-8.25 | $ 31.65 | 3.09 % | $ 50.8 M | USA |
 |
Personalis
PSNL
|
-33.64 | $ 5.5 | -7.75 % | $ 326 M | USA |
 |
Heska Corporation
HSKA
|
-4.81 | - | - | $ 1.31 B | USA |
 |
Interpace Biosciences
IDXG
|
18.26 | $ 1.93 | - | $ 8.54 M | USA |
 |
Senseonics Holdings
SENS
|
-111.94 | $ 7.17 | -1.44 % | $ 299 M | USA |
 |
Medpace Holdings
MEDP
|
116.53 | $ 411.6 | -2.32 % | $ 11.9 B | USA |
 |
QIAGEN N.V.
QGEN
|
8.07 | - | - | $ 10.6 B | Niderland |
 |
Motus GI Holdings
MOTS
|
-443.13 | - | -34.28 % | $ 263 K | Israel |
 |
Biomerica
BMRA
|
-125.14 | $ 2.19 | 0.46 % | $ 5.03 M | USA |
 |
ICON Public Limited Company
ICLR
|
4.69 | $ 101.98 | -1.19 % | $ 8.41 B |  Irlanda |
 |
Thermo Fisher Scientific
TMO
|
14.5 | $ 471.36 | 0.71 % | $ 178 B | USA |
 |
Laboratory Corporation of America Holdings
LH
|
16.06 | $ 260.02 | -1.29 % | $ 21.6 B | USA |
 |
Trinity Biotech plc
TRIB
|
0.08 | $ 0.61 | -5.2 % | $ 61.9 M | Irlanda |
 |
Neogen Corporation
NEOG
|
-51.22 | $ 9.24 | -2.22 % | $ 2 B | USA |
 |
Celcuity
CELC
|
-171.24 | $ 120.62 | -4.03 % | $ 5.64 B | USA |
 |
Twist Bioscience Corporation
TWST
|
-28.81 | $ 59.61 | -2.2 % | $ 3.57 B | USA |
 |
NeoGenomics
NEO
|
-9.11 | $ 8.97 | 4.17 % | $ 1.15 B | USA |
 |
Myriad Genetics
MYGN
|
-105.22 | $ 4.88 | 0.93 % | $ 452 M | USA |
 |
Natera
NTRA
|
-76.66 | $ 200.99 | -1.67 % | $ 19.8 B | USA |
 |
Quest Diagnostics Incorporated
DGX
|
21.7 | $ 194.95 | -0.85 % | $ 21.6 B | USA |
 |
Invitae Corporation
NVTA
|
-93.18 | - | - | $ 21.2 M | USA |